Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice
about
Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice.The molecular specificity of insulin autoantibodies.New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies.TGF-beta signaling is required for the function of insulin-reactive T regulatory cellsImmunotherapy of type 1 diabetes: lessons for other autoimmune diseases.Impact of intranasal insulin on insulin antibody affinity and isotypes in young children with HLA-conferred susceptibility to type 1 diabetes.Novel diagnostic and therapeutic approaches for autoimmune diabetes--a prime time to treat insulitis as a disease.The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance.Neuroendocrine immuno-ontogeny of the pathogenesis of autoimmune disease in the nonobese diabetic (NOD) mouse.A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.Otelixizumab: a novel agent for the prevention of type 1 diabetes mellitus.Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice.Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?Metabolically inactive insulin: friend or foe in the prevention of autoimmune diabetes?The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
P2860
Q34035323-CCF637CF-7996-4D75-A489-9A115832D125Q34056958-1A7DBC35-6906-416B-9906-9518CE91E549Q34564255-4165D7F4-FE1C-4B55-B82F-D557F946FFA1Q34576601-B48A0D67-72AE-44D5-B1F9-47BCF5BA3E9EQ34731064-082D50FD-A3AF-4397-B904-954ED9B94ABDQ35043241-33A655DF-B4B7-47FD-AB4C-C6ACFC8FEEC6Q35108159-D6A523FE-F9FF-4D75-ADB5-C71072FF11B6Q35531898-E03450BF-1985-4579-B87C-67CE9B5838B8Q35823962-491057D1-95C0-4780-8902-CF88D633EFB7Q36011349-7C875788-AC6D-47FD-AE3C-98AF1225B95DQ37931276-A79F902C-9811-4353-AAF0-D165261427EDQ38813347-6DB054E1-46E9-4C23-9271-FC90AF8C6A3EQ42569246-444B25A4-E064-4971-90EB-043EF4C8DE5EQ42739489-AFA5C225-22C7-4F7A-9DFF-9914EB4D3DA9Q45943982-5C106559-ECCF-4777-AEE3-876576B59590Q57816736-C42E201A-D445-4B4A-8171-E48CEB3C999D
P2860
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice
@en
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.
@nl
type
label
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice
@en
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.
@nl
prefLabel
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice
@en
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.
@nl
P2093
P2860
P356
P1476
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice
@en
P2093
P2860
P304
P356
10.1172/JCI119654
P407
P577
1997-09-01T00:00:00Z